Published in Medical Letter on the CDC and FDA, March 7th, 2004
The treatment, developed over the last few years by Svend Freytag, PhD, division head of radiation oncology at Henry Ford, is a new approach that uses gene therapy to enhance the effectiveness of radiation therapy.
Later in 2004, a clinical trial will begin involving 130 patients. In one group, 65 patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.